Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 5/20 | 0.37 |
| ▸ | CES1 | P23141 | 4/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 7/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7689221 | 0.78 | ALDH1A1 (0.39) | ALDH1A1CES2CES1AKR1B1PPARG | |
| SCHEMBL5319006 | 0.74 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL16669992 | 0.74 | ALDH1A1 (0.36) | ALDH1A1CES2CES1PPARGPPARA | |
| SCHEMBL27848826 | 0.73 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL29004569 | 0.72 | ALDH1A1 (0.38) | ALDH1A1CES2CES1AKR1B1PPARG | |
| SCHEMBL14167475 | 0.71 | FDPS (0.43) | ALDH1A1CES2CES1 | |
| SCHEMBL19389271 | 0.71 | ALDH1A1 (0.43) | ALDH1A1CES2 | |
| SCHEMBL11596859 | 0.71 | FDPS (0.43) | ALDH1A1CES2CES1 | |
| SCHEMBL29596855 | 0.71 | ALDH1A1 (0.48) | ALDH1A1CES2 | |
| SCHEMBL1117314 | 0.71 | ALDH1A1 (0.39) | ALDH1A1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070149606-A1 | Process for producing phenylacetic acid derivative | DAIICHI PHARMACEUTICAL CO.,LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
| EP-1698611-A1 | PROCESS FOR PRODUCING PHENYLACETIC ACID DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149606-A1 | Process for producing phenylacetic acid derivative | UGT1A4, VPS4B, CYP3A4 | ALDH1A1 43/4885CES2 710/4885CES1 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.